Orgenesis Inc (ORGS)
0.501
-0.02
(-3.47%)
USD |
NASDAQ |
Apr 24, 16:00
0.501
0.00 (0.00%)
After-Hours: 20:00
Orgenesis Cash from Operations (TTM): -14.84M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -14.84M |
| September 30, 2023 | -25.10M |
| June 30, 2023 | -28.87M |
| March 31, 2023 | -29.37M |
| December 31, 2022 | -24.92M |
| September 30, 2022 | -16.63M |
| June 30, 2022 | -20.02M |
| March 31, 2022 | -25.11M |
| December 31, 2021 | -26.87M |
| September 30, 2021 | -69.63M |
| June 30, 2021 | -71.26M |
| March 31, 2021 | -68.90M |
| December 31, 2020 | -78.05M |
| September 30, 2020 | -35.52M |
| June 30, 2020 | -27.89M |
| March 31, 2020 | -22.40M |
| December 31, 2019 | -13.22M |
| September 30, 2019 | -13.72M |
| June 30, 2019 | -16.94M |
| March 31, 2019 | -18.10M |
| November 30, 2018 | -15.68M |
| August 31, 2018 | -12.87M |
| May 31, 2018 | -8.96M |
| February 28, 2018 | -6.323M |
| November 30, 2017 | -3.833M |
| Date | Value |
|---|---|
| August 31, 2017 | -4.042M |
| May 31, 2017 | -3.395M |
| February 28, 2017 | -2.043M |
| November 30, 2016 | -3.783M |
| August 31, 2016 | -3.838M |
| May 31, 2016 | -3.855M |
| February 29, 2016 | -3.406M |
| November 30, 2015 | -2.706M |
| August 31, 2015 | -2.376M |
| May 31, 2015 | -1.525M |
| February 28, 2015 | -1.57M |
| November 30, 2014 | -1.429M |
| August 31, 2014 | -1.562M |
| May 31, 2014 | -1.937M |
| February 28, 2014 | -2.046M |
| November 30, 2013 | -1.989M |
| August 31, 2013 | -1.827M |
| May 31, 2013 | -1.587M |
| February 28, 2013 | -1.376M |
| November 30, 2012 | -1.052M |
| August 31, 2012 | -0.7529M |
| May 31, 2012 | -0.4432M |
| February 29, 2012 | -0.1251M |
| November 30, 2011 | -0.0002M |
| August 31, 2011 | 0.0006M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-78.05M
Minimum
Dec 2020
-13.22M
Maximum
Dec 2019
-33.12M
Average
-25.11M
Median
Mar 2022
Cash from Operations (TTM) Benchmarks
| Altimmune Inc | -75.81M |
| Verastem Inc | -86.46M |
| Oragenics Inc | -7.291M |
| Actinium Pharmaceuticals Inc | -47.34M |
| Dare Bioscience Inc | -38.86M |